Changes in serum potassium with concomitant administration of renin-angiotensin system agents and potassium-sparing diuretics: U.S. cohort study using electronic health record data
JAPhA Pharmacotherapy · 2024
DOI: 10.1016/j.japhar.2023.100002 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift JAPhA Pharmacotherapy, 2024. Verfasst von M. Sakil Syeed und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agency for Healthcare Research and Quality.
Abstract (Originalsprache)
Potassium sparing diuretics (KSD) and, renin-angiotensin system (RAS) agents [including angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-receptor blockers (ARB)] are commonly prescribed for the management of hypertension, cardiovascular diseases, and in diabetic nephropathy. However, there is a concern of developing hyperkalemia when these drugs are concomitantly use. This study investigates the change in serum potassium when concomitant administration of RAS agents (ACEI/ARB) and KSD. Retrospective observational study using the CERNER Health Facts® (HF) database. Electronic health records from unique patient hospitalization encounters were used to compare change in the serum potassium among five different cohorts: ACEI, ARB, KSD, ACEI-KSD and ARB-KSD and a non-RAS non-KSD exposed one (acetaminophen cohort). Descriptive on the cohorts and the risk for increase in potassium serum was estimated by generalized linear regression. A total of 5,816 patients’ unique encounters were analyzed. Following admission 5.2% (N=303) had serum potassium >5.5 mmol/L. Results showed a significant increase in serum potassium when concomitant use of KSD and RAS agents and when only using KSD compared to the control acetaminophen group (all p
Förderung
- Agency for Healthcare Research and Quality
Zitieren
APA
Syeed, M. S., Gomez-Lumbreras, A., Tan, M., & Malone, D. C. (2024). Changes in serum potassium with concomitant administration of renin-angiotensin system agents and potassium-sparing diuretics: U.S. cohort study using electronic health record data. JAPhA Pharmacotherapy. https://doi.org/10.1016/j.japhar.2023.100002
Vancouver
Syeed MS, Gomez-Lumbreras A, Tan M, Malone DC. Changes in serum potassium with concomitant administration of renin-angiotensin system agents and potassium-sparing diuretics: U.S. cohort study using electronic health record data. JAPhA Pharmacotherapy. 2024. doi:10.1016/j.japhar.2023.100002
BibTeX
@article{Syeed2024,
author = {Syeed, M. Sakil and Gomez-Lumbreras, Ainhoa and Tan, Malinda and Malone, Daniel C.},
title = {Changes in serum potassium with concomitant administration of renin-angiotensin system agents and potassium-sparing diuretics: U.S. cohort study using electronic health record data},
journal = {JAPhA Pharmacotherapy},
year = {2024},
doi = {10.1016/j.japhar.2023.100002}
}
EUVIMED